Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetvaxbiomedical.com
CategoryBioTech
Phone913-492-2221
Employees
DescriptionA clinical stage development company

Offices

Lenexa, USA
8006 Reeder Street
Lenexa, KS, 66214-1554
USA

Funding

TOTAL $2M
FUNDING TOTAL $2M
Venture Round, 1/2013
$2M
DEBT TOTAL $2M
Debt, 8/2010
$2M

Tags

TVAX Biomedical

TVAX Biomedical is a clinical stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The company’s proprietary therapeutic approach offers the promise of improved clinical outcomes, low toxicity and the potential for fundamentally changing the way cancer is treated. TVAX Immunotherapy is a unique personalized combination of cancer cell vaccination and “killer” T cell treatment. This treatment has demonstrated the potential to effectively treat numerous cancers without many of the undesirable side effects associated with radiation and chemotherapy. A key distinction between TVAX and other cancer immunotherapy companies is that TVI uses its patented approach to combine both cancer vaccination and activated “killer” T cell treatment. While each of these separate approaches has demonstrated therapeutic potential, neither has demonstrated the efficacy to be a viable standalone treatment.

Recent Milestones

Videos

Screenshots

TVAX Biomedical screenshot
Above: TVAX Biomedical
Uploaded: 1/8/13

Sources

  1. SEC (sec.gov) [edit]
  2. TVAX Biomedical Raises $2.0M (finsmes.com) [edit]
Edit This Page
Last Edited 2/12/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy